1. This randomized clinical trial demonstrated that multigenetic pharmacogenomics-guided treatment (MPGT) had higher response and remission rates in the treatment ...
1. Compared to healthy controls, participants with a first episode of schizophrenia had reduced expression of a microglia-associated protein, CSF1R. ...
1. For patients with schizophrenia, symptomatic response to antipsychotic medication at 2 and 4 weeks after initiation can appropriately predict ...
1. In this systematic review, religion-based spirituality was found to be an important factor in the recovery of people with ...
Spirituality may promote mental health recovery for people with schizophrenia in Southeast Asia 1. In this systematic review, religion-based spirituality ...
1. Incidence of total adverse events and specific adverse events were similar between the emraclidine groups and placebo. 2. There ...
1. Excitatory Noninvasive Brain Stimulation Intervention (NIBS) protocols over the left dorsolateral prefrontal cortex were associated with significantly large improvements ...
1. In this study, both individual patient and study-level analyses revealed a negative correlation between placebo response and treatment effect, ...
1. There was no evidence of superiority among the different antipsychotics. 2. Choice of antipsychotic regimen for schizophrenia maintenance should ...
1. Patients with prior episodes of critical illness requiring ICU admission were found to have an elevated risk of suicide ...
